ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized immune cells battle High-Risk leukemia in new trial
Disease control Recruiting nowThis study is testing whether a personalized cell therapy called obecabtagene autoleucel (obe-cel) can help control high-risk B-cell acute lymphocytic leukemia (ALL) when given after initial chemotherapy. Researchers will enroll about 30 adults with newly diagnosed, high-risk ALL…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Radical transplant trial aims to replace diseased blood systems
Disease control Recruiting nowThis study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC